Colgate-Palmolive Company (NYSE:CL) Director Sells $579,760.00 in Stock

Colgate-Palmolive Company (NYSE:CL) Director John T. Cahill sold 8,000 shares of the business’s stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $72.47, for a total value of $579,760.00. Following the sale, the director now owns 31,786 shares in the company, valued at approximately $2,303,531.42. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Shares of Colgate-Palmolive Company (NYSE:CL) traded down 0.18% on Friday, hitting $71.17. The stock had a trading volume of 1,779,498 shares. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The firm has a 50 day moving average of $72.38 and a 200-day moving average of $72.86. The firm has a market capitalization of $62.69 billion, a price-to-earnings ratio of 26.45 and a beta of 0.80. Colgate-Palmolive also saw unusually large options trading on Tuesday. Traders purchased 12,928 put options on the stock. This is an increase of 560% compared to the average volume of 1,959 put options.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. The business had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business’s revenue was down .5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.70 EPS. Equities analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, July 14th. This represents a $1.60 annualized dividend and a yield of 2.24%. Colgate-Palmolive’s payout ratio is 59.48%.

ILLEGAL ACTIVITY WARNING: This article was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this article on another site, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this article can be viewed at https://stocknewstimes.com/2017/08/18/colgate-palmolive-company-nysecl-director-sells-579760-00-in-stock-updated-updated.html.

CL has been the topic of a number of analyst reports. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 3rd. Jefferies Group LLC reiterated a “hold” rating and issued a $76.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, May 17th. Bank of America Corporation upped their price target on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, May 31st. BidaskClub lowered Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research report on Wednesday, July 12th. Finally, Vetr lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price target on the stock. in a research report on Wednesday, May 17th. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $75.82.

A number of hedge funds have recently bought and sold shares of the stock. Blue Chip Partners Inc. boosted its stake in Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock valued at $132,000 after buying an additional 8 shares during the last quarter. Cue Financial Group Inc. boosted its stake in Colgate-Palmolive by 0.3% in the second quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock valued at $360,000 after buying an additional 14 shares during the last quarter. Alpha Windward LLC boosted its stake in Colgate-Palmolive by 0.6% in the first quarter. Alpha Windward LLC now owns 2,829 shares of the company’s stock valued at $207,000 after buying an additional 18 shares during the last quarter. Cornerstone Financial Partners LLC boosted its stake in Colgate-Palmolive by 0.5% in the second quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock valued at $282,000 after buying an additional 19 shares during the last quarter. Finally, Northstar Group Inc. boosted its stake in Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock valued at $356,000 after buying an additional 20 shares during the last quarter. 73.69% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply